Skip to main content

fosgonimeton

Generic: Fosgonimeton Sodium

fosgonimeton: 2 clinical trials tracked.

fosgonimeton evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about fosgonimeton, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trial Registry Records (2)

Open-Label Extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in Subjects With Mild to Moderate Alzheimer's Disease

NCT04886063Registry updated 2025-04-01·Phase 2/Phase 3·LONA
Terminated

Primary endpoint: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]

Interventionalopen423 targetStarted 2021-06Completion 2024-101 site · United StatesLeonaBio

A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease

NCT04488419Registry updated 2025-04-04·Phase 2/Phase 3·LONA
Completed

Primary endpoint: Global Statistical Test (GST) Score

InterventionalRandomizedquadruple554 enrolledStarted 2020-09Completion 2024-071 site · United StatesLeonaBio